nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—HTR2C—Sorafenib—kidney cancer	0.101	0.147	CbGbCtD
Prochlorperazine—CYP2D6—Temsirolimus—kidney cancer	0.0995	0.144	CbGbCtD
Prochlorperazine—CYP3A4—Everolimus—kidney cancer	0.0936	0.136	CbGbCtD
Prochlorperazine—CYP3A4—Temsirolimus—kidney cancer	0.0633	0.0918	CbGbCtD
Prochlorperazine—CYP2D6—Pazopanib—kidney cancer	0.0523	0.0759	CbGbCtD
Prochlorperazine—CYP2D6—Erlotinib—kidney cancer	0.0373	0.0541	CbGbCtD
Prochlorperazine—CYP3A4—Pazopanib—kidney cancer	0.0332	0.0482	CbGbCtD
Prochlorperazine—CYP2D6—Sorafenib—kidney cancer	0.0303	0.044	CbGbCtD
Prochlorperazine—CYP2D6—Vinblastine—kidney cancer	0.0299	0.0435	CbGbCtD
Prochlorperazine—CYP3A4—Erlotinib—kidney cancer	0.0237	0.0344	CbGbCtD
Prochlorperazine—CYP3A4—Paclitaxel—kidney cancer	0.0217	0.0315	CbGbCtD
Prochlorperazine—CYP3A4—Sorafenib—kidney cancer	0.0193	0.028	CbGbCtD
Prochlorperazine—CYP3A4—Vinblastine—kidney cancer	0.019	0.0276	CbGbCtD
Prochlorperazine—CYP3A4—Vincristine—kidney cancer	0.0187	0.0272	CbGbCtD
Prochlorperazine—CYP2D6—Doxorubicin—kidney cancer	0.0184	0.0267	CbGbCtD
Prochlorperazine—CYP3A4—Sunitinib—kidney cancer	0.0156	0.0227	CbGbCtD
Prochlorperazine—CYP3A4—Doxorubicin—kidney cancer	0.0117	0.017	CbGbCtD
Prochlorperazine—Ethopropazine—BCHE—kidney cancer	0.000547	0.138	CrCbGaD
Prochlorperazine—Erythema—Dactinomycin—kidney cancer	0.000522	0.0017	CcSEcCtD
Prochlorperazine—Oedema—Erlotinib—kidney cancer	0.00052	0.00169	CcSEcCtD
Prochlorperazine—Infection—Erlotinib—kidney cancer	0.000516	0.00168	CcSEcCtD
Prochlorperazine—Leukopenia—Sorafenib—kidney cancer	0.000513	0.00167	CcSEcCtD
Prochlorperazine—Pruritus—Temsirolimus—kidney cancer	0.000512	0.00167	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Doxorubicin—kidney cancer	0.00051	0.00166	CcSEcCtD
Prochlorperazine—Amenorrhoea—Doxorubicin—kidney cancer	0.00051	0.00166	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Erlotinib—kidney cancer	0.000509	0.00166	CcSEcCtD
Prochlorperazine—Skin disorder—Erlotinib—kidney cancer	0.000505	0.00164	CcSEcCtD
Prochlorperazine—Pancytopenia—Paclitaxel—kidney cancer	0.000505	0.00164	CcSEcCtD
Prochlorperazine—Angioedema—Sunitinib—kidney cancer	0.000504	0.00164	CcSEcCtD
Prochlorperazine—Hypotension—Everolimus—kidney cancer	0.000503	0.00164	CcSEcCtD
Prochlorperazine—Oedema peripheral—Gemcitabine—kidney cancer	0.0005	0.00163	CcSEcCtD
Prochlorperazine—Cough—Sorafenib—kidney cancer	0.0005	0.00163	CcSEcCtD
Prochlorperazine—Leukopenia—Sunitinib—kidney cancer	0.000493	0.00161	CcSEcCtD
Prochlorperazine—Insomnia—Everolimus—kidney cancer	0.000487	0.00158	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Paclitaxel—kidney cancer	0.000485	0.00158	CcSEcCtD
Prochlorperazine—Weight increased—Paclitaxel—kidney cancer	0.000484	0.00157	CcSEcCtD
Prochlorperazine—Pruritus—Pazopanib—kidney cancer	0.000482	0.00157	CcSEcCtD
Prochlorperazine—Cough—Sunitinib—kidney cancer	0.000481	0.00156	CcSEcCtD
Prochlorperazine—Erythema multiforme—Gemcitabine—kidney cancer	0.00048	0.00156	CcSEcCtD
Prochlorperazine—Dyspnoea—Everolimus—kidney cancer	0.00048	0.00156	CcSEcCtD
Prochlorperazine—Urinary retention—Capecitabine—kidney cancer	0.00048	0.00156	CcSEcCtD
Prochlorperazine—Cardiac arrest—Capecitabine—kidney cancer	0.00048	0.00156	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Paclitaxel—kidney cancer	0.000479	0.00156	CcSEcCtD
Prochlorperazine—Somnolence—Everolimus—kidney cancer	0.000479	0.00156	CcSEcCtD
Prochlorperazine—Dizziness—Temsirolimus—kidney cancer	0.000479	0.00156	CcSEcCtD
Prochlorperazine—Convulsion—Sunitinib—kidney cancer	0.000477	0.00155	CcSEcCtD
Prochlorperazine—Dry mouth—Sorafenib—kidney cancer	0.000477	0.00155	CcSEcCtD
Prochlorperazine—Dyskinesia—Doxorubicin—kidney cancer	0.000477	0.00155	CcSEcCtD
Prochlorperazine—Insomnia—Erlotinib—kidney cancer	0.00047	0.00153	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Sorafenib—kidney cancer	0.000467	0.00152	CcSEcCtD
Prochlorperazine—Leukopenia—Dactinomycin—kidney cancer	0.000467	0.00152	CcSEcCtD
Prochlorperazine—Infection—Sorafenib—kidney cancer	0.000464	0.00151	CcSEcCtD
Prochlorperazine—Dyspnoea—Erlotinib—kidney cancer	0.000463	0.00151	CcSEcCtD
Prochlorperazine—Constipation—Vinblastine—kidney cancer	0.000462	0.0015	CcSEcCtD
Prochlorperazine—Constipation—Everolimus—kidney cancer	0.00046	0.0015	CcSEcCtD
Prochlorperazine—Clomipramine—GSTP1—kidney cancer	0.000459	0.116	CrCbGaD
Prochlorperazine—Gait disturbance—Doxorubicin—kidney cancer	0.000459	0.00149	CcSEcCtD
Prochlorperazine—Dry mouth—Sunitinib—kidney cancer	0.000459	0.00149	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Sorafenib—kidney cancer	0.000458	0.00149	CcSEcCtD
Prochlorperazine—Rash—Temsirolimus—kidney cancer	0.000456	0.00149	CcSEcCtD
Prochlorperazine—Dermatitis—Temsirolimus—kidney cancer	0.000456	0.00148	CcSEcCtD
Prochlorperazine—Skin disorder—Sorafenib—kidney cancer	0.000454	0.00148	CcSEcCtD
Prochlorperazine—Arrhythmia—Gemcitabine—kidney cancer	0.000454	0.00148	CcSEcCtD
Prochlorperazine—Headache—Temsirolimus—kidney cancer	0.000453	0.00148	CcSEcCtD
Prochlorperazine—Dizziness—Pazopanib—kidney cancer	0.000451	0.00147	CcSEcCtD
Prochlorperazine—Oedema—Sunitinib—kidney cancer	0.00045	0.00146	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Doxorubicin—kidney cancer	0.000448	0.00146	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Doxorubicin—kidney cancer	0.000448	0.00146	CcSEcCtD
Prochlorperazine—Triflupromazine—BCHE—kidney cancer	0.000448	0.113	CrCbGaD
Prochlorperazine—Infection—Sunitinib—kidney cancer	0.000447	0.00145	CcSEcCtD
Prochlorperazine—Constipation—Erlotinib—kidney cancer	0.000444	0.00145	CcSEcCtD
Prochlorperazine—Dermatitis contact—Doxorubicin—kidney cancer	0.000443	0.00144	CcSEcCtD
Prochlorperazine—Erythema—Gemcitabine—kidney cancer	0.000442	0.00144	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Sunitinib—kidney cancer	0.00044	0.00143	CcSEcCtD
Prochlorperazine—Skin disorder—Sunitinib—kidney cancer	0.000437	0.00142	CcSEcCtD
Prochlorperazine—Asthma—Capecitabine—kidney cancer	0.000436	0.00142	CcSEcCtD
Prochlorperazine—Influenza—Capecitabine—kidney cancer	0.000436	0.00142	CcSEcCtD
Prochlorperazine—Dysphagia—Capecitabine—kidney cancer	0.000436	0.00142	CcSEcCtD
Prochlorperazine—Rash—Pazopanib—kidney cancer	0.00043	0.0014	CcSEcCtD
Prochlorperazine—Dermatitis—Pazopanib—kidney cancer	0.00043	0.0014	CcSEcCtD
Prochlorperazine—Agitation—Vincristine—kidney cancer	0.000428	0.00139	CcSEcCtD
Prochlorperazine—Headache—Pazopanib—kidney cancer	0.000427	0.00139	CcSEcCtD
Prochlorperazine—Oedema—Dactinomycin—kidney cancer	0.000426	0.00139	CcSEcCtD
Prochlorperazine—Body temperature increased—Everolimus—kidney cancer	0.000426	0.00139	CcSEcCtD
Prochlorperazine—Infection—Dactinomycin—kidney cancer	0.000423	0.00138	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Doxorubicin—kidney cancer	0.000421	0.00137	CcSEcCtD
Prochlorperazine—Oedema peripheral—Paclitaxel—kidney cancer	0.000419	0.00136	CcSEcCtD
Prochlorperazine—Leukopenia—Vincristine—kidney cancer	0.000417	0.00136	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Dactinomycin—kidney cancer	0.000417	0.00136	CcSEcCtD
Prochlorperazine—Dyspnoea—Sorafenib—kidney cancer	0.000417	0.00136	CcSEcCtD
Prochlorperazine—Pancytopenia—Capecitabine—kidney cancer	0.000414	0.00135	CcSEcCtD
Prochlorperazine—Body temperature increased—Erlotinib—kidney cancer	0.000411	0.00134	CcSEcCtD
Prochlorperazine—Coma—Doxorubicin—kidney cancer	0.000409	0.00133	CcSEcCtD
Prochlorperazine—Insomnia—Sunitinib—kidney cancer	0.000407	0.00132	CcSEcCtD
Prochlorperazine—Convulsion—Vincristine—kidney cancer	0.000404	0.00131	CcSEcCtD
Prochlorperazine—Erythema multiforme—Paclitaxel—kidney cancer	0.000402	0.00131	CcSEcCtD
Prochlorperazine—Dyspnoea—Sunitinib—kidney cancer	0.000401	0.0013	CcSEcCtD
Prochlorperazine—Constipation—Sorafenib—kidney cancer	0.0004	0.0013	CcSEcCtD
Prochlorperazine—Hypersensitivity—Vinblastine—kidney cancer	0.000398	0.0013	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Capecitabine—kidney cancer	0.000398	0.0013	CcSEcCtD
Prochlorperazine—Weight increased—Capecitabine—kidney cancer	0.000397	0.00129	CcSEcCtD
Prochlorperazine—Hypersensitivity—Everolimus—kidney cancer	0.000397	0.00129	CcSEcCtD
Prochlorperazine—Leukopenia—Gemcitabine—kidney cancer	0.000396	0.00129	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Capecitabine—kidney cancer	0.000393	0.00128	CcSEcCtD
Prochlorperazine—Cough—Gemcitabine—kidney cancer	0.000386	0.00126	CcSEcCtD
Prochlorperazine—Constipation—Sunitinib—kidney cancer	0.000385	0.00125	CcSEcCtD
Prochlorperazine—Pruritus—Everolimus—kidney cancer	0.000381	0.00124	CcSEcCtD
Prochlorperazine—Oedema—Vincristine—kidney cancer	0.00038	0.00124	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Vincristine—kidney cancer	0.00038	0.00124	CcSEcCtD
Prochlorperazine—Arrhythmia—Paclitaxel—kidney cancer	0.00038	0.00124	CcSEcCtD
Prochlorperazine—Jaundice—Capecitabine—kidney cancer	0.000379	0.00123	CcSEcCtD
Prochlorperazine—Infection—Vincristine—kidney cancer	0.000378	0.00123	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Vincristine—kidney cancer	0.000372	0.00121	CcSEcCtD
Prochlorperazine—Urticaria—Sorafenib—kidney cancer	0.000371	0.00121	CcSEcCtD
Prochlorperazine—Photosensitivity—Doxorubicin—kidney cancer	0.00037	0.00121	CcSEcCtD
Prochlorperazine—Erythema—Paclitaxel—kidney cancer	0.00037	0.0012	CcSEcCtD
Prochlorperazine—Body temperature increased—Sorafenib—kidney cancer	0.000369	0.0012	CcSEcCtD
Prochlorperazine—Pruritus—Erlotinib—kidney cancer	0.000368	0.0012	CcSEcCtD
Prochlorperazine—Agranulocytosis—Capecitabine—kidney cancer	0.000363	0.00118	CcSEcCtD
Prochlorperazine—Eczema—Doxorubicin—kidney cancer	0.000362	0.00118	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000361	0.00117	CcSEcCtD
Prochlorperazine—Oedema—Gemcitabine—kidney cancer	0.000361	0.00117	CcSEcCtD
Prochlorperazine—Nervousness—Paclitaxel—kidney cancer	0.00036	0.00117	CcSEcCtD
Prochlorperazine—Infection—Gemcitabine—kidney cancer	0.000359	0.00117	CcSEcCtD
Prochlorperazine—Dizziness—Vinblastine—kidney cancer	0.000357	0.00116	CcSEcCtD
Prochlorperazine—Dizziness—Everolimus—kidney cancer	0.000356	0.00116	CcSEcCtD
Prochlorperazine—Muscle spasms—Paclitaxel—kidney cancer	0.000356	0.00116	CcSEcCtD
Prochlorperazine—Body temperature increased—Sunitinib—kidney cancer	0.000356	0.00116	CcSEcCtD
Prochlorperazine—Hypotension—Vincristine—kidney cancer	0.000355	0.00116	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Gemcitabine—kidney cancer	0.000353	0.00115	CcSEcCtD
Prochlorperazine—Skin disorder—Gemcitabine—kidney cancer	0.000351	0.00114	CcSEcCtD
Prochlorperazine—Vision blurred—Paclitaxel—kidney cancer	0.000349	0.00114	CcSEcCtD
Prochlorperazine—Tremor—Paclitaxel—kidney cancer	0.000347	0.00113	CcSEcCtD
Prochlorperazine—Increased appetite—Doxorubicin—kidney cancer	0.000346	0.00113	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000345	0.00112	CcSEcCtD
Prochlorperazine—Hypersensitivity—Sorafenib—kidney cancer	0.000344	0.00112	CcSEcCtD
Prochlorperazine—Insomnia—Vincristine—kidney cancer	0.000344	0.00112	CcSEcCtD
Prochlorperazine—Oedema peripheral—Capecitabine—kidney cancer	0.000344	0.00112	CcSEcCtD
Prochlorperazine—Dizziness—Erlotinib—kidney cancer	0.000344	0.00112	CcSEcCtD
Prochlorperazine—Agitation—Paclitaxel—kidney cancer	0.00034	0.00111	CcSEcCtD
Prochlorperazine—Rash—Everolimus—kidney cancer	0.00034	0.0011	CcSEcCtD
Prochlorperazine—Dermatitis—Everolimus—kidney cancer	0.000339	0.0011	CcSEcCtD
Prochlorperazine—Headache—Vinblastine—kidney cancer	0.000339	0.0011	CcSEcCtD
Prochlorperazine—Angioedema—Paclitaxel—kidney cancer	0.000338	0.0011	CcSEcCtD
Prochlorperazine—Headache—Everolimus—kidney cancer	0.000337	0.0011	CcSEcCtD
Prochlorperazine—Hypotension—Gemcitabine—kidney cancer	0.000337	0.0011	CcSEcCtD
Prochlorperazine—Body temperature increased—Dactinomycin—kidney cancer	0.000337	0.0011	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000336	0.00109	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Doxorubicin—kidney cancer	0.000333	0.00108	CcSEcCtD
Prochlorperazine—Leukopenia—Paclitaxel—kidney cancer	0.000331	0.00108	CcSEcCtD
Prochlorperazine—Hypersensitivity—Sunitinib—kidney cancer	0.000331	0.00108	CcSEcCtD
Prochlorperazine—Pruritus—Sorafenib—kidney cancer	0.000331	0.00108	CcSEcCtD
Prochlorperazine—Erythema multiforme—Capecitabine—kidney cancer	0.00033	0.00107	CcSEcCtD
Prochlorperazine—Rash—Erlotinib—kidney cancer	0.000328	0.00107	CcSEcCtD
Prochlorperazine—Dermatitis—Erlotinib—kidney cancer	0.000327	0.00106	CcSEcCtD
Prochlorperazine—Insomnia—Gemcitabine—kidney cancer	0.000326	0.00106	CcSEcCtD
Prochlorperazine—Headache—Erlotinib—kidney cancer	0.000325	0.00106	CcSEcCtD
Prochlorperazine—Constipation—Vincristine—kidney cancer	0.000325	0.00106	CcSEcCtD
Prochlorperazine—Cough—Paclitaxel—kidney cancer	0.000323	0.00105	CcSEcCtD
Prochlorperazine—Dyspnoea—Gemcitabine—kidney cancer	0.000322	0.00105	CcSEcCtD
Prochlorperazine—Somnolence—Gemcitabine—kidney cancer	0.000321	0.00104	CcSEcCtD
Prochlorperazine—Convulsion—Paclitaxel—kidney cancer	0.000321	0.00104	CcSEcCtD
Prochlorperazine—Pruritus—Sunitinib—kidney cancer	0.000318	0.00104	CcSEcCtD
Prochlorperazine—Hypersensitivity—Dactinomycin—kidney cancer	0.000314	0.00102	CcSEcCtD
Prochlorperazine—Arrhythmia—Capecitabine—kidney cancer	0.000312	0.00101	CcSEcCtD
Prochlorperazine—Cardiac arrest—Doxorubicin—kidney cancer	0.000309	0.00101	CcSEcCtD
Prochlorperazine—Dizziness—Sorafenib—kidney cancer	0.000309	0.00101	CcSEcCtD
Prochlorperazine—Constipation—Gemcitabine—kidney cancer	0.000309	0.001	CcSEcCtD
Prochlorperazine—Dry mouth—Paclitaxel—kidney cancer	0.000308	0.001	CcSEcCtD
Prochlorperazine—Erythema—Capecitabine—kidney cancer	0.000304	0.000989	CcSEcCtD
Prochlorperazine—Oedema—Paclitaxel—kidney cancer	0.000302	0.000983	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000302	0.000983	CcSEcCtD
Prochlorperazine—Body temperature increased—Vincristine—kidney cancer	0.000301	0.000978	CcSEcCtD
Prochlorperazine—Infection—Paclitaxel—kidney cancer	0.0003	0.000977	CcSEcCtD
Prochlorperazine—Dizziness—Sunitinib—kidney cancer	0.000297	0.000968	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000296	0.000963	CcSEcCtD
Prochlorperazine—Rash—Sorafenib—kidney cancer	0.000295	0.000959	CcSEcCtD
Prochlorperazine—Dermatitis—Sorafenib—kidney cancer	0.000294	0.000958	CcSEcCtD
Prochlorperazine—Skin disorder—Paclitaxel—kidney cancer	0.000293	0.000955	CcSEcCtD
Prochlorperazine—Headache—Sorafenib—kidney cancer	0.000293	0.000953	CcSEcCtD
Prochlorperazine—Muscle spasms—Capecitabine—kidney cancer	0.000292	0.00095	CcSEcCtD
Prochlorperazine—Vision blurred—Capecitabine—kidney cancer	0.000286	0.000932	CcSEcCtD
Prochlorperazine—Body temperature increased—Gemcitabine—kidney cancer	0.000285	0.000928	CcSEcCtD
Prochlorperazine—Tremor—Capecitabine—kidney cancer	0.000285	0.000926	CcSEcCtD
Prochlorperazine—Rash—Sunitinib—kidney cancer	0.000284	0.000923	CcSEcCtD
Prochlorperazine—Dermatitis—Sunitinib—kidney cancer	0.000283	0.000922	CcSEcCtD
Prochlorperazine—Hypotension—Paclitaxel—kidney cancer	0.000282	0.000919	CcSEcCtD
Prochlorperazine—Headache—Sunitinib—kidney cancer	0.000282	0.000917	CcSEcCtD
Prochlorperazine—Asthma—Doxorubicin—kidney cancer	0.000281	0.000915	CcSEcCtD
Prochlorperazine—Influenza—Doxorubicin—kidney cancer	0.000281	0.000915	CcSEcCtD
Prochlorperazine—Dysphagia—Doxorubicin—kidney cancer	0.000281	0.000915	CcSEcCtD
Prochlorperazine—Hypersensitivity—Vincristine—kidney cancer	0.00028	0.000912	CcSEcCtD
Prochlorperazine—Eosinophilia—Doxorubicin—kidney cancer	0.000278	0.000905	CcSEcCtD
Prochlorperazine—Insomnia—Paclitaxel—kidney cancer	0.000273	0.000889	CcSEcCtD
Prochlorperazine—Leukopenia—Capecitabine—kidney cancer	0.000272	0.000885	CcSEcCtD
Prochlorperazine—Dyspnoea—Paclitaxel—kidney cancer	0.000269	0.000876	CcSEcCtD
Prochlorperazine—Somnolence—Paclitaxel—kidney cancer	0.000269	0.000874	CcSEcCtD
Prochlorperazine—Rash—Dactinomycin—kidney cancer	0.000268	0.000874	CcSEcCtD
Prochlorperazine—Pancytopenia—Doxorubicin—kidney cancer	0.000267	0.000869	CcSEcCtD
Prochlorperazine—Cough—Capecitabine—kidney cancer	0.000265	0.000863	CcSEcCtD
Prochlorperazine—Constipation—Paclitaxel—kidney cancer	0.000258	0.000841	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000257	0.000835	CcSEcCtD
Prochlorperazine—Weight increased—Doxorubicin—kidney cancer	0.000256	0.000832	CcSEcCtD
Prochlorperazine—Pruritus—Gemcitabine—kidney cancer	0.000255	0.000831	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Doxorubicin—kidney cancer	0.000254	0.000825	CcSEcCtD
Prochlorperazine—Dry mouth—Capecitabine—kidney cancer	0.000253	0.000823	CcSEcCtD
Prochlorperazine—Dizziness—Vincristine—kidney cancer	0.000252	0.000819	CcSEcCtD
Prochlorperazine—Drowsiness—Doxorubicin—kidney cancer	0.000251	0.000815	CcSEcCtD
Prochlorperazine—Oedema—Capecitabine—kidney cancer	0.000248	0.000807	CcSEcCtD
Prochlorperazine—Infection—Capecitabine—kidney cancer	0.000246	0.000802	CcSEcCtD
Prochlorperazine—Jaundice—Doxorubicin—kidney cancer	0.000244	0.000795	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Capecitabine—kidney cancer	0.000243	0.00079	CcSEcCtD
Prochlorperazine—Skin disorder—Capecitabine—kidney cancer	0.000241	0.000784	CcSEcCtD
Prochlorperazine—Urticaria—Paclitaxel—kidney cancer	0.00024	0.000781	CcSEcCtD
Prochlorperazine—Rash—Vincristine—kidney cancer	0.00024	0.00078	CcSEcCtD
Prochlorperazine—Dermatitis—Vincristine—kidney cancer	0.00024	0.00078	CcSEcCtD
Prochlorperazine—Body temperature increased—Paclitaxel—kidney cancer	0.000239	0.000777	CcSEcCtD
Prochlorperazine—Headache—Vincristine—kidney cancer	0.000238	0.000775	CcSEcCtD
Prochlorperazine—Agranulocytosis—Doxorubicin—kidney cancer	0.000234	0.000761	CcSEcCtD
Prochlorperazine—Hypotension—Capecitabine—kidney cancer	0.000232	0.000754	CcSEcCtD
Prochlorperazine—Rash—Gemcitabine—kidney cancer	0.000228	0.00074	CcSEcCtD
Prochlorperazine—Dermatitis—Gemcitabine—kidney cancer	0.000227	0.00074	CcSEcCtD
Prochlorperazine—Headache—Gemcitabine—kidney cancer	0.000226	0.000736	CcSEcCtD
Prochlorperazine—Insomnia—Capecitabine—kidney cancer	0.000224	0.00073	CcSEcCtD
Prochlorperazine—Hypersensitivity—Paclitaxel—kidney cancer	0.000223	0.000724	CcSEcCtD
Prochlorperazine—Oedema peripheral—Doxorubicin—kidney cancer	0.000222	0.000721	CcSEcCtD
Prochlorperazine—Dyspnoea—Capecitabine—kidney cancer	0.000221	0.000719	CcSEcCtD
Prochlorperazine—Domperidone—ABCB1—kidney cancer	0.000217	0.0547	CrCbGaD
Prochlorperazine—Chlorpromazine—BCHE—kidney cancer	0.000216	0.0545	CrCbGaD
Prochlorperazine—Pruritus—Paclitaxel—kidney cancer	0.000214	0.000696	CcSEcCtD
Prochlorperazine—Erythema multiforme—Doxorubicin—kidney cancer	0.000213	0.000692	CcSEcCtD
Prochlorperazine—Constipation—Capecitabine—kidney cancer	0.000212	0.00069	CcSEcCtD
Prochlorperazine—Arrhythmia—Doxorubicin—kidney cancer	0.000201	0.000654	CcSEcCtD
Prochlorperazine—Dizziness—Paclitaxel—kidney cancer	0.0002	0.00065	CcSEcCtD
Prochlorperazine—Urticaria—Capecitabine—kidney cancer	0.000197	0.000641	CcSEcCtD
Prochlorperazine—Body temperature increased—Capecitabine—kidney cancer	0.000196	0.000638	CcSEcCtD
Prochlorperazine—Erythema—Doxorubicin—kidney cancer	0.000196	0.000637	CcSEcCtD
Prochlorperazine—Rash—Paclitaxel—kidney cancer	0.000191	0.00062	CcSEcCtD
Prochlorperazine—Dermatitis—Paclitaxel—kidney cancer	0.00019	0.000619	CcSEcCtD
Prochlorperazine—Nervousness—Doxorubicin—kidney cancer	0.00019	0.000619	CcSEcCtD
Prochlorperazine—Headache—Paclitaxel—kidney cancer	0.000189	0.000616	CcSEcCtD
Prochlorperazine—Muscle spasms—Doxorubicin—kidney cancer	0.000188	0.000613	CcSEcCtD
Prochlorperazine—Vision blurred—Doxorubicin—kidney cancer	0.000185	0.000601	CcSEcCtD
Prochlorperazine—Hypersensitivity—Capecitabine—kidney cancer	0.000183	0.000594	CcSEcCtD
Prochlorperazine—Nefazodone—ABCB1—kidney cancer	0.00018	0.0454	CrCbGaD
Prochlorperazine—Agitation—Doxorubicin—kidney cancer	0.00018	0.000586	CcSEcCtD
Prochlorperazine—Triflupromazine—ABCB1—kidney cancer	0.000176	0.0443	CrCbGaD
Prochlorperazine—Pruritus—Capecitabine—kidney cancer	0.000175	0.000571	CcSEcCtD
Prochlorperazine—Leukopenia—Doxorubicin—kidney cancer	0.000175	0.00057	CcSEcCtD
Prochlorperazine—Cough—Doxorubicin—kidney cancer	0.000171	0.000556	CcSEcCtD
Prochlorperazine—Convulsion—Doxorubicin—kidney cancer	0.00017	0.000552	CcSEcCtD
Prochlorperazine—Clozapine—CYP1A1—kidney cancer	0.000169	0.0427	CrCbGaD
Prochlorperazine—Aripiprazole—ABCB1—kidney cancer	0.000167	0.0423	CrCbGaD
Prochlorperazine—Trazodone—ABCB1—kidney cancer	0.000167	0.0421	CrCbGaD
Prochlorperazine—Dizziness—Capecitabine—kidney cancer	0.000164	0.000534	CcSEcCtD
Prochlorperazine—Dry mouth—Doxorubicin—kidney cancer	0.000163	0.000531	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Doxorubicin—kidney cancer	0.00016	0.00052	CcSEcCtD
Prochlorperazine—Oedema—Doxorubicin—kidney cancer	0.00016	0.00052	CcSEcCtD
Prochlorperazine—Infection—Doxorubicin—kidney cancer	0.000159	0.000517	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Doxorubicin—kidney cancer	0.000156	0.000509	CcSEcCtD
Prochlorperazine—Rash—Capecitabine—kidney cancer	0.000156	0.000509	CcSEcCtD
Prochlorperazine—Dermatitis—Capecitabine—kidney cancer	0.000156	0.000508	CcSEcCtD
Prochlorperazine—Clobazam—ABCB1—kidney cancer	0.000156	0.0394	CrCbGaD
Prochlorperazine—Headache—Capecitabine—kidney cancer	0.000155	0.000505	CcSEcCtD
Prochlorperazine—Skin disorder—Doxorubicin—kidney cancer	0.000155	0.000505	CcSEcCtD
Prochlorperazine—Hypotension—Doxorubicin—kidney cancer	0.000149	0.000486	CcSEcCtD
Prochlorperazine—Insomnia—Doxorubicin—kidney cancer	0.000145	0.00047	CcSEcCtD
Prochlorperazine—Dyspnoea—Doxorubicin—kidney cancer	0.000142	0.000464	CcSEcCtD
Prochlorperazine—Somnolence—Doxorubicin—kidney cancer	0.000142	0.000462	CcSEcCtD
Prochlorperazine—Constipation—Doxorubicin—kidney cancer	0.000137	0.000445	CcSEcCtD
Prochlorperazine—Fluphenazine—ABCB1—kidney cancer	0.000135	0.0341	CrCbGaD
Prochlorperazine—Urticaria—Doxorubicin—kidney cancer	0.000127	0.000413	CcSEcCtD
Prochlorperazine—Body temperature increased—Doxorubicin—kidney cancer	0.000126	0.000411	CcSEcCtD
Prochlorperazine—Clomipramine—ABCB1—kidney cancer	0.000123	0.0311	CrCbGaD
Prochlorperazine—Chlorprothixene—ABCB1—kidney cancer	0.000123	0.031	CrCbGaD
Prochlorperazine—Hypersensitivity—Doxorubicin—kidney cancer	0.000118	0.000383	CcSEcCtD
Prochlorperazine—Pruritus—Doxorubicin—kidney cancer	0.000113	0.000368	CcSEcCtD
Prochlorperazine—Promethazine—ABCB1—kidney cancer	0.000109	0.0276	CrCbGaD
Prochlorperazine—Trifluoperazine—ABCB1—kidney cancer	0.000108	0.0272	CrCbGaD
Prochlorperazine—Dizziness—Doxorubicin—kidney cancer	0.000106	0.000344	CcSEcCtD
Prochlorperazine—Quetiapine—ABCB1—kidney cancer	0.000105	0.0264	CrCbGaD
Prochlorperazine—Rash—Doxorubicin—kidney cancer	0.000101	0.000328	CcSEcCtD
Prochlorperazine—Dermatitis—Doxorubicin—kidney cancer	0.000101	0.000328	CcSEcCtD
Prochlorperazine—Headache—Doxorubicin—kidney cancer	0.0001	0.000326	CcSEcCtD
Prochlorperazine—Desipramine—ABCB1—kidney cancer	9.93e-05	0.0251	CrCbGaD
Prochlorperazine—Clozapine—ABCB1—kidney cancer	9e-05	0.0227	CrCbGaD
Prochlorperazine—Chlorpromazine—ABCB1—kidney cancer	8.47e-05	0.0214	CrCbGaD
Prochlorperazine—Imipramine—ABCB1—kidney cancer	8.42e-05	0.0213	CrCbGaD
